InsiderClue
Stocks · Health care · Pharmaceutical Preparations

MapLight Therapeutics, Inc.

MPLT Clue Score44
United States Fiscal year ends December CIK 0001770069
$8.83 -3.50% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $8.83 −51.85% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 27 Oct 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2024Operating income−82.9Net income−77.6EPS, diluted−105.38Fiscal year 2025Operating income−169.1Net income−161.2EPS, diluted−18.56
FY2024FY2025
Operating income −82.9 −169.1
Net income −77.6 −161.2
Growth
EPS, diluted −105.38 −18.56

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow−78.8Capital expenditure−0.8Free cash flow−79.6Fiscal year 2025Operating cash flow−138.1Capital expenditure−0.5Free cash flow−138.6
FY2024FY2025
Operating cash flow −78.8 −138.1
Capital expenditure −0.8 −0.5
Free cash flow −79.6 −138.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2024Cash38.3Shareholders’ equity−193.6Fiscal year 2025Cash46.7Shareholders’ equity458.4
FY2024FY2025
Cash 38.3 46.7
Shareholders’ equity −193.6 458.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −35.2%
−56.7% −33.6%
Balance and payout
15.9% 4.4%